Cargando…
Juvenile Idiopathic Arthritis Associated Uveitis
Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease. The development of associated uveitis represents a significant risk for serious complications, including permanent loss of vision. Initiation of early treatment is important for controlling JIA-uveitis, but the disea...
Autores principales: | Carlsson, Emil, Beresford, Michael W., Ramanan, Athimalaipet V., Dick, Andrew D., Hedrich, Christian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393258/ https://www.ncbi.nlm.nih.gov/pubmed/34438537 http://dx.doi.org/10.3390/children8080646 |
Ejemplares similares
-
Juvenile idiopathic arthritis-associated uveitis
por: Clarke, Sarah L. N., et al.
Publicado: (2016) -
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
por: Acharya, Nisha R., et al.
Publicado: (2020) -
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
por: Ramanan, Athimalaipet V, et al.
Publicado: (2020) -
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
por: Sen, Ethan S., et al.
Publicado: (2017) -
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
por: Ramanan, Athimalaipet V, et al.
Publicado: (2014)